1. Introduction
Thermal therapies, from ancient baths to modern cryochambers, have long been used for their physiological effects. Historically, heat was employed by Egyptians and Romans for pain and fever, while cold applications have transitioned from traditional medicine to modern cryotherapy for their analgesic and anti-inflammatory properties (1–4). Contrast therapy, alternating heat and cold, is thought to induce a “vascular pump” effect, reducing oedema (5–7).
Despite centuries of use, evidence remains fragmented. Recent reviews highlight modest effects—such as improved blood flow and reduced soreness—but emphasize a lack of standardized protocols and methodological quality (5, 8). This uncertainty persists while patients often prefer “passive” treatments, especially in early rehabilitation stages where kinesiophobia, pain, and low motivation hinder active exercise (9–13). Adherence to exercise programs often falls below 70% due to discomfort or perceived lack of progress (14).
Recently, Finnish sauna (FS) and whole-body cryostimulation (WBC) have gained attention. These passive modalities offer immediate sensory relief and may alleviate movement-related anxiety (14, 15). FS (80–100°C) is associated with improved cardiovascular function and autonomic regulation (16), while WBC (–110 to −140°C) modulates pro-inflammatory cytokines and sympathetic tone (17–19). A crucial mechanism likely involves the vagus nerve, which regulates inflammation and stress responses. Both heat and cold can influence vagal tone, promoting systemic homeostasis (20–23). Although heat triggers sympathetic activation, repeated exposure (sauna) induces a parasympathetic shift, reflected in increased heart rate variability (HRV) (24, 25).
This opinion paper aims to explore the current scientific evidence regarding the use of FS and WBC in clinical rehabilitation. It examines their physiological mechanisms, therapeutic applications, and the feasibility of integrating them into multidisciplinary programs.
2. Systemic heat-based treatment (FS)
FS involves brief exposure to dry air (80–100°C) with 10%–20% humidity. Sessions typically last 5–20 min, increasing heart rate to 120–150 bpm, mimicking moderate aerobic stress (26–28).
2.1. Physiological evidence
Whole-body heat therapy triggers adaptations primarily through several mechanisms such as:
Vascular Shear Stress: Enhances endothelial nitric oxide synthase (eNOS) activity, increasing nitric oxide (NO) bioavailability, which improves arterial elasticity and peripheral circulation (29, 30).
Heat Shock Proteins (HSPs): Increased HSP70 and HSP90 levels protect protein integrity, mitigate apoptosis, and shield cells from oxidative stress (31–33).
Anti-inflammatory Effects: Reduction in pro-inflammatory markers and oxidative stress contributes to metabolic resilience (34, 35).
Autonomic Regulation: Repeated thermal exposure induces a enhances autonomic flexibility, improving the body's ability to dynamically balance sympathetic activation with parasympathetic recovery, characterized by increased HRV and a reduction in resting sympathetic tone (25).
Nociception: Heat activates TRPV1 channels on sensory neurons, modulating C-fiber activity and stimulating analgesic responses via central mechanisms (36, 37).
2.2. Clinical effects of FS bathing
Habitual sauna use is linked to reduced risks of hypertension, cardiovascular disease, and neurodegenerative disorders (31, 38, 39). In rehabilitation, FS alleviates musculoskeletal pain, osteoarthritis, and chronic headaches (16, 36). It modulates autonomic balance, reducing sympathetic tone while increasing parasympathetic activity during recovery (16, 40). Notably, the levels of norepinephrine reached during sauna exposure are comparable to those observed after maximal exercise, indicating a potent autonomic stimulus (36). Hormonal responses include transient increases in norepinephrine, cortisol, and growth hormone, which may confer adaptive benefits (34, 41).
Preliminary evidence suggests that heat therapy may influence circulating biomarkers of glucose and lipid metabolism, insulin resistance and cardiac injury (e.g., troponin T); however, further studies are required to establish these associations definitively (42, 43).
2.3. Safety and contraindications
FS is generally safe for stable coronary artery disease or compensated heart failure (44, 45). However, it is contraindicated in unstable angina, recent myocardial infarction, severe aortic stenosis, or uncontrolled hypertension (25, 46). Combining sauna with cold plunges can trigger dangerous autonomic surges in vulnerable individuals (34, 45). Alcohol consumption is strictly discouraged due to the risk of hypotension and impaired thermoregulation (25). Furthermore, FS is contraindicated for individuals prone to syncope or orthostatic intolerance, as the significant peripheral vasodilation may exacerbate hemodynamic instability (25). Caution is also required for thermosensitive Multiple Sclerosis (MS) patients, as elevated internal temperatures can lead to a transient increase in neurological symptoms (46, 47).
2.4. Knowledge gaps
Despite documented benefits, the clinical application of FS in rehabilitation remains limited. Most evidence is observational or based on general cardiovascular cohorts, leaving a void in standardized protocols for multidisciplinary frameworks (16, 29). Specifically, a lack of RCTs targeting functional recovery in stroke, pulmonary disease, or complex musculoskeletal populations prevents the translation of sauna-induced physiological gains into motor or cognitive outcomes. Furthermore, while safe for stable cardiac patients, the absence of data on physical frailty or severe autonomic dysregulation hinders its broader utility. Future research must define precise therapeutic “dosing”—temperature, duration, and frequency—to responsibly integrate passive heat into mainstream rehabilitative care.
2.5. Potential applications
The systemic effects of FS have a wide range of applications in rehabilitative medicine. In cardiovascular rehabilitation, for example, heat exposure can be used alongside treatment for stable coronary artery disease or heart failure to improve endothelial function and reduce vascular resistance (29, 34). For chronic pain conditions such as fibromyalgia, osteoarthritis and rheumatoid arthritis, FS has been shown to be effective in reducing joint stiffness and elevating pain thresholds through nociceptor modulation (26, 36, 42).
In respiratory and metabolic care, preliminary evidence suggests improved lung function in obstructive pulmonary diseases and favorable glucose and lipid modulation in metabolic syndrome (42, 43). Beyond the physical benefits, the psychological impact, including reduced anxiety and improved sleep, supports neurorehabilitation by enhancing patient motivation for active exercise (41). While the use of FS in post-stroke recovery and in the treatment of neurodegenerative diseases shows promise due to improved autonomic balance, further validation through rigorous clinical trials is required in these areas.
3. Systemic cold-based treatments
WBC involves brief exposure to −110°C to −160°C air for 1–3 min, triggering neuroendocrine, immune, and circulatory adaptations (48–50). It has recently emerged as a promising non-pharmacological intervention in the rehabilitation field to modulate chronic pain, reduce neuroinflammation, and serve as a “priming” tool to facilitate the transition to active therapeutic exercise (51).
3.1. Emerging physiological evidence
Extreme cold triggers systemic adaptations through several physiological pathways, such as:
Neuroendocrine Activation: stimulation of the hypothalamic-pituitary-adrenal (HPA) axis and a simultaneous stimulation of the sympathetic-adrenal-medullary axis to release adrenaline and noradrenaline, enhancing arousal (52).
Vascular Modulation: Initial catecholamine-induced vasoconstriction followed by reactive vasodilation, which improves tissue perfusion and microvascular reactivity (53).
Immune Response: Downregulation of pro-inflammatory cytokines (such as TNF-α, IL-6, and IL-1β) and upregulation of the anti-inflammatory cytokine IL-10 (54, 55).
Nociceptive Signaling: Activation of TRPM8 ion channels and release of β-endorphins, which suppress pain signaling and elevate pain thresholds (56, 57).
Emerging evidence also suggests neuroprotective potential through cold-shock proteins (e.g., RBM3) and brain-derived neurotrophic factor (BDNF) modulation (50, 58).
3.2. Clinical effects
WBC serves as a multi-target adjunctive therapy in rehabilitation. It supports metabolic health by activating brown adipose tissue (BAT) and enhancing thermogenic lipolysis, aiding in weight management and insulin sensitivity (59–61). In neurological and pain syndromes, it reduces fatigue, improves sleep quality, and alleviates symptoms of Multiple Sclerosis (MS), fibromyalgia, and central sensitization (47, 62, 63). In post-COVID-19 rehabilitation, especially for patients with obesity, WBC facilitates engagement in exercise by reducing musculoskeletal discomfort and systemic inflammation (53). WBC has also been shown to exert anti-inflammatory effects, primarily through a shift in cytokine profiles such as TNF-α, IL-6, and IL-1β, while promoting an increase in IL-10, a key anti-inflammatory cytokine (64, 65).
3.3. Adverse events and contraindications
WBC is generally safe in controlled settings, though transient side effects like shivering, mild headache, and skin redness can occur (66). Rare but significant reactions include blood pressure spikes, transient arrhythmias, and vasospastic responses, particularly in patients with compromised autonomic function (67). Adverse events like cold urticaria or frostbite are typically associated with inadequate medical screening or safety protocol violations (66, 68, 69).
Current consensus distinguishes between absolute, relative, and situational contraindications to ensure safe clinical application (70). Absolute contraindications include unstable cardiac conditions (recent MI, severe aortic stenosis), cold-induced disorders (Raynaud's II/III, cryoglobulinemia), acute DVT, and uncontrolled epilepsy. Relative or situational contraindications include controlled arrhythmia, mild autonomic dysfunction, fever, or recent surgery. Proper risk stratification, comparable to ergometric testing, is essential for the safe integration of WBC into multidisciplinary rehabilitation.
With proper risk stratification, WBC can be administered safely in sports and clinical rehabilitation settings.
3.4. Knowledge gaps
Despite clinical promise, WBC lacks established consensus on optimal parameters (temperature, duration, and frequency), hindering the formulation of standardized protocols (70). Many mechanisms remain inadequately elucidated or extrapolated from small, uncontrolled cohorts (18, 51, 59). There is a scarcity of direct clinical investigations into long-term metabolic effects in obesity and a lack of robust randomized controlled trials (RCTs) with validated functional outcomes for chronic pain. Future research must prioritize uniform protocols, mechanistic clarity, and longitudinal cost-effectiveness studies.
3.5. Potential application
WBC is increasingly utilized as an adjunctive therapy for chronic conditions due to its systemic effects on inflammation, metabolism, and neuroendocrine function. In neurological rehabilitation, WBC has shown significant benefits for patients with MS, specifically improving fatigue, sleep quality, mood, and functional performance (47, 71). Similarly, in chronic pain syndromes like fibromyalgia, WBC demonstrates substantial reductions in pain severity, anxiety, and disease impact, with benefits sustained over time (55, 62, 66, 72).
In post-COVID-19 rehabilitation, particularly for individuals with obesity, WBC integrated into multidisciplinary protocols has resulted in meaningful reductions in body mass, systemic inflammation, and perceived fatigue (53). Its applications also extend to neuropathic and musculoskeletal pain, including phantom limb pain and kinesiophobia in chronic shoulder disorders, where it enhances patient engagement by providing immediate symptomatic relief (58, 73, 74). While preliminary evidence in Parkinson's disease (75), spasticity (76), and rheumatic disorders (51, 77) is promising, robust clinical trials are necessary to define optimal protocols and long-term outcomes.
4. Discussion
Integrating systemic thermal therapies such as FS and WBC into rehabilitation represents a paradigm shift, moving away from purely active models and towards “priming” approaches that are consistent with interventions such as nature exposure and mind-body practices (78–80). These modalities act as physiological boosters, which are particularly beneficial during the early stages of recovery when kinesiophobia, pain and fatigue can hinder exercise. By modulating the autonomic nervous system, specifically via the vagus nerve, thermal stress can improve systemic homeostasis and psychological readiness (25, 46). This convergence towards optimized autonomic flexibility and HRV creates a “priming zone” (see Figure 1). This homeostatic window optimizes the physiological response, reducing kinesiophobia and allowing the transition to active exercise protocols to be facilitated.
Figure 1.
This picture illustrates the use of FS and WBC as physiological “priming” tools. The lateral panels distinguish between acute responses and adaptive gains for both the heat and cold modalities. These pathways converge in the central zone, optimizing vagal tone and HRV and promoting systemic autonomic homeostasis. This provides symptomatic relief and facilitates the clinical transition to active exercise protocols.
However, translating these biological signals into clinical practice remains challenging. One critical issue is the “dose-response” relationship: the ideal temperature, duration and frequency remain undefined for most pathological cohorts. Furthermore, while preclinical data on heat shock proteins (HSPs) and cold-shock proteins (RBM3) suggest neuroprotective mechanisms, their role in human recovery remains speculative (81). The absence of validated biomarkers further complicates efforts to personalize treatment.
Another significant gap lies in the interaction between thermal stress and other rehabilitation components. It is currently unclear whether thermal therapies act synergistically with specific exercise protocols, or whether concurrent medications alter the expected cardiovascular and immune responses. Moreover, most research focuses on the acute effects; the long-term sustainability of the benefits, and whether a “maintenance dose” is required, remain largely unexplored.
4.1. Limits
This paper is limited by the heterogeneous nature of current literature and the lack of systematic appraisal, which may introduce selection bias. The reliance on pilot studies, case reports, and surrogate markers limits firm conclusions about efficacy and safety. Additionally, the lack of robust comparative data between heat and cold modalities makes it difficult to define specific indications for each. Mechanisms like BAT activation or neuroimmune modulation require further study in human clinical settings. Until high-quality RCTs are available, these promising applications should be interpreted with caution.
5. Conclusion
Systemic heat- and cold-based therapies, such as FS and WBC, are emerging as promising additional strategies in the field of rehabilitation medicine. Their ability to trigger diverse systemic responses, including cardiovascular, neuromuscular, metabolic, autonomic and immunological responses, makes them valuable tools for addressing chronic pain, fatigue and neuroinflammation. Although these interventions are traditionally viewed as “passive”, they can act as a rehabilitation booster, particularly during the early stages of recovery when pain and deconditioning often impede progress.
Furthermore, high levels of patient satisfaction and immediate symptomatic relief can help to overcome common barriers such as low motivation and poor treatment adherence. However, despite the encouraging preliminary findings, their integration into structured protocols is limited by a lack of standardized dosing and long-term evidence. Robust clinical trials are essential to establish therapeutic guidelines and clarify interactions with other interventions. Until then, these modalities should be considered valuable yet experimental components of multidisciplinary care and only be prescribed following rigorous medical screening and individualized clinical reasoning.
Funding Statement
The author(s) declared that financial support was not received for this work and/or its publication.
Footnotes
Edited by: Tobias Kammerer, Cologne University Hospital, Germany
Reviewed by: Thad E. Wilson, University of Kentucky, United States
Nisha Shantakumari, Ajman University, United Arab Emirates
Author contributions
AA: Conceptualization, Writing – original draft. FV: Writing – original draft, Conceptualization. LC: Investigation, Writing – review & editing, Data curation. CM: Methodology, Writing – review & editing. SL: Methodology, Writing – review & editing. JF: Writing – original draft, Data curation. PC: Supervision, Writing – review & editing. AG: Investigation, Writing – review & editing.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
- 1.Kamioka H, Tsutani K, Okuizumi H, Mutoh Y, Ohta M, Handa S, et al. Effectiveness of aquatic exercise and balneotherapy: a summary of systematic reviews based on randomized controlled trials of water immersion therapies. J Epidemiol. (2010) 20(1):2–12. 10.2188/jea.JE20090030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Maccarone MC, Regazzo G, Contessa P, Scanu A, Masiero S. Healing with thermal mineral-rich waters: the role of spa therapy in post-surgical rehabilitation. Int J Biometeorol. (2025) 69:2125–9. 10.1007/s00484-025-02920-9 [DOI] [PubMed] [Google Scholar]
- 3.Allan R, Malone J, Alexander J, Vorajee S, Ihsan M, Gregson W, et al. Cold for centuries: a brief history of cryotherapies to improve health, injury and post-exercise recovery. Eur J Appl Physiol. (2022) 122(5):1153–62. 10.1007/s00421-022-04915-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kwiecien SY, McHugh MP. The cold truth: the role of cryotherapy in the treatment of injury and recovery from exercise. Eur J Appl Physiol. (2021) 121(8):2125–42. 10.1007/s00421-021-04683-8 [DOI] [PubMed] [Google Scholar]
- 5.Breger Stanton DE, Lazaro R, Macdermid JC. A systematic review of the effectiveness of contrast baths. J Hand Ther. (2009) 22(1):57–69. 10.1016/j.jht.2008.08.001 [DOI] [PubMed] [Google Scholar]
- 6.Leonardi G, Portaro S, Milardi D, Bonanno F, Sanzarello I, Bruschetta D, et al. Mechanisms and efficacy of contrast therapy for musculoskeletal painful disease: a scoping review. J Clin Med. (2025) 14(5):1441. 10.3390/jcm14051441 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mawhinney C, Jones H, Low DA, Green DJ, Howatson G, Gregson W. Influence of cold-water immersion on limb blood flow after resistance exercise. Eur J Sport Sci. (2017) 17:519–29. 10.1080/17461391.2017.1279222 [DOI] [PubMed] [Google Scholar]
- 8.Wang ZR, Ni GX. Is it time to put traditional cold therapy in rehabilitation of soft-tissue injuries out to pasture? World J Clin Cases. (2021) 9(17):4116–22. 10.12998/wjcc.v9.i17.4116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Alasfour M, Bajnaid M, Hobani S, Alrwaily M. Treatment preferences of patients with chronic low back pain in physical therapy clinics in Saudi Arabia: a cross-sectional study. PeerJ. (2025) 13:e19274. 10.7717/peerj.19274 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Blasche G, Melchart H, Leitner D, Marktl W. Personality does not predict treatment preference, treatment experience does: a study of four complementary pain treatments. Forsch Komplementmed. (2007) 14(5):274–80. 10.1159/000108010 [DOI] [PubMed] [Google Scholar]
- 11.Dawson AP, Schluter PJ, Hodges PW, Stewart S, Turner C. Fear of movement, passive coping, manual handling, and severe or radiating pain increase the likelihood of sick leave due to low back pain. Pain. (2011) 152(7):1517–24. 10.1016/j.pain.2011.02.041 [DOI] [PubMed] [Google Scholar]
- 12.Vlaeyen JWS, Kole-Snijders AMJ, Rotteveel AM, Ruesink RM, Heuts PHTG. The role of fear of movement/(re)injury in pain disability. J Occup Rehabil. (1995) 5(4):235–52. 10.1007/BF02109988 [DOI] [PubMed] [Google Scholar]
- 13.Vecchio M, Chiaramonte R, Romano M, Pavone P, Musumeci G, Mauro GL. A systematic review of pharmacologic and rehabilitative treatment of small fiber neuropathies. Diagnostics. (2020) 10(12):1022. 10.3390/diagnostics10121022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Jack K, McLean SM, Moffett JK, Gardiner E. Barriers to treatment adherence in physiotherapy outpatient clinics: a systematic review. Man Ther. (2010) 15(3):220–8. 10.1016/j.math.2009.12.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bernhardsson S, Larsson MEH, Johansson K, Öberg B. “In the physio we trust”: a qualitative study on patients' Preferences for physiotherapy. Physiother Theory Pract. (2017) 33(7):535–49. 10.1080/09593985.2017.1328720 [DOI] [PubMed] [Google Scholar]
- 16.Laukkanen T, Kunutsor SK, Khan H, Willeit P, Zaccardi F, Laukkanen JA. Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study. BMC Med. (2018) 16(1):219. 10.1186/s12916-018-1198-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.He J, Zhang X, Ge Z, Shi J, Guo S, Chen J. Whole-body cryotherapy can reduce the inflammatory response in humans: a meta-analysis based on 11 randomized controlled trials. Sci Rep. (2025) 15(1):7759. 10.1038/s41598-025-90396-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lombardi G, Ziemann E, Banfi G. Whole-body cryotherapy in athletes: from therapy to stimulation. An updated review of the literature. Front Physiol. (2017) 8:258. 10.3389/fphys.2017.00258 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lubkowska A, Szyguła Z, Chlubek D, Banfi G. The effect of prolonged whole-body cryostimulation treatment with different amounts of sessions on chosen pro- and anti-inflammatory cytokines levels in healthy men. Scand J Clin Lab Invest. (2011) 71(5):419–25. 10.3109/00365513.2011.580859 [DOI] [PubMed] [Google Scholar]
- 20.Louis J, Theurot D, Filliard JR, Volondat M, Dugué B, Dupuy O. The use of whole-body cryotherapy: time- and dose-response investigation on circulating blood catecholamines and heart rate variability. Eur J Appl Physiol. (2020) 120(8):1733–43. 10.1007/s00421-020-04406-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Jungmann M, Vencatachellum S, Van Ryckeghem D, Vögele C. Effects of cold stimulation on cardiac-vagal activation in healthy participants: randomized controlled trial. JMIR Form Res. (2018) 2(2):e10257. 10.2196/10257 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mooventhan A, Nivethitha L. Effects of ice massage of the head and spine on heart rate variability in healthy volunteers. J Integr Med. (2016) 14(4):306–10. 10.1016/S2095-4964(16)60266-2 [DOI] [PubMed] [Google Scholar]
- 23.Storniolo JL, Esposti R, Cavallari P. Heart rate kinetics and sympatho-vagal balance accompanying a maximal sprint test. Front Psychol. (2019) 10:2950. 10.3389/fpsyg.2019.02950 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cui X, Tian L, Li Z, Ren Z, Zha K, Wei X, et al. On the variability of heart rate variability-evidence from prospective study of healthy young college students. Entropy. (2020) 22(11):1302. 10.3390/e22111302 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Laukkanen JA, Laukkanen T, Kunutsor SK. Cardiovascular and other health benefits of sauna bathing: a review of the evidence. Mayo Clin Proc. (2018) 93(8):1111–21. 10.1016/j.mayocp.2018.04.008 [DOI] [PubMed] [Google Scholar]
- 26.Laukkanen JA, Kunutsor SK. The multifaceted benefits of passive heat therapies for extending the healthspan: a comprehensive review with a focus on Finnish sauna. Temperature. (2024) 11(1):27–51. 10.1080/23328940.2023.2300623 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sastriques-Dunlop S, Elizondo-Benedetto S, Zayed MA. Sauna use as a novel management approach for cardiovascular health and peripheral arterial disease. Front Cardiovasc Med. (2025) 12:1537194. 10.3389/fcvm.2025.1537194 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Engström Å, Hägglund H, Lee E, Wennberg M, Söderberg S, Andersson M. Sauna bathing in northern Sweden: results from the MONICA study 2022. Int J Circumpolar Health. (2024) 83(1):2419698. 10.1080/22423982.2024.2419698 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Brunt VE, Minson CT. Heat therapy: mechanistic underpinnings and applications to cardiovascular health. J Appl Physiol. (2021) 130(6):1684–704. 10.1152/japplphysiol.00141.2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ohori T, Nozawa T, Ihori H, Shida T, Sobajima M, Matsuki A, et al. Effect of repeated sauna treatment on exercise tolerance and endothelial function in patients with chronic heart failure. Am J Cardiol. (2012) 109(1):100–4. 10.1016/j.amjcard.2011.08.014 [DOI] [PubMed] [Google Scholar]
- 31.Brunt VE, Wiedenfeld-Needham K, Comrada LN, Minson CT. Passive heat therapy protects against endothelial cell hypoxia-reoxygenation via effects of elevations in temperature and circulating factors. J Physiol. (2018) 596(20):4831–45. 10.1113/JP276559 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lubrano E, Mazas PF, Freiwald J, Krüger K, Grattagliano I, Mur E, et al. An international multidisciplinary delphi-based consensus on heat therapy in musculoskeletal pain. Pain Ther. (2023) 12(1):93–110. 10.1007/s40122-022-00419-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Scanu A, Maccarone MC, Caldara F, Regazzo G, Luisetto R, Masiero S. Thermal water reduces the inflammatory process induced by the SARS-CoV-2 spike protein in human airway epithelial cells in vitro. Biomedicines. (2024) 12(12):2917. 10.3390/biomedicines12122917 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kunutsor SK, Häkkinen A, Zaccardi F, Laukkanen T, Lee E, Willeit P, et al. Short-term effects of Finnish sauna bathing on blood-based markers of cardiovascular function in non-naive sauna users. Heart Vessels. (2018) 33(12):1515–24. 10.1007/s00380-018-1202-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Kunutsor SK, Laukkanen JA. Does the combination of Finnish sauna bathing and other lifestyle factors confer additional health benefits? A review of the evidence. Mayo Clin Proc. (2023) 98(6):915–26. 10.1016/j.mayocp.2023.01.008 [DOI] [PubMed] [Google Scholar]
- 36.Chabal C. Fundaments of thermal analgesia in humans: exploring new methods of pain relief. Anesth Pain Res. (2021) 5. 10.33425/2639-846X.1048 [DOI] [Google Scholar]
- 37.Shuba YM. Beyond neuronal heat sensing: diversity of TRPV1 heat-capsaicin receptor-channel functions. Front Cell Neurosci. (2020) 14:612480. 10.3389/fncel.2020.612480 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bots ML, Hofman A, Grobbee DE. Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the rotterdam study. Stroke. (1997) 28(12):2442–7. 10.1161/01.STR.28.12.2442 [DOI] [PubMed] [Google Scholar]
- 39.Kunutsor SK, Mäkikallio TH, Khan H, Laukkanen T, Kauhanen J, Laukkanen JA. Sauna bathing reduces the risk of venous thromboembolism: a prospective cohort study. Eur J Epidemiol. (2019) 34(10):983–6. 10.1007/s10654-019-00544-z [DOI] [PubMed] [Google Scholar]
- 40.Henderson KN, Killen LG, O'Neal EK, Waldman HS. The cardiometabolic health benefits of sauna exposure in individuals with high-stress occupations. A mechanistic review. Int J Environ Res Public Health. (2021) 18(3):1105. 10.3390/ijerph18031105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Hussain J, Cohen M. Clinical effects of regular dry sauna bathing: a systematic review. Evid Based Complement Alternat Med. (2018) 2018:1857413. 10.1155/2018/1857413 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Bock PM, Kowalewski LS, Ayres LR, Russo MKB, Leites GT, Martins AF, et al. Effect of heat therapy compared with strength training on metabolic profile, heat shock response, inflammation, cardiovascular responses and microbiota in individuals with type 2 diabetes: study protocol of a randomized trial. Sao Paulo Med J. (2025) 143(3):e2024040. 10.1590/1516-3180-2024.0040.r1.13082024 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ely BR, Clayton ZS, McCurdy CE, Pfeiffer J, Needham KW, Comrada LN, et al. Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome. Am J Physiol Endocrinol Metab. (2019) 317(1):E172–82. 10.1152/ajpendo.00549.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zaccardi F, Laukkanen T, Willeit P, Kunutsor SK, Kauhanen J, Laukkanen JA. Sauna bathing and incident hypertension: a prospective cohort study. Am J Hypertens. (2017) 30(11):1120–5. 10.1093/ajh/hpx102 [DOI] [PubMed] [Google Scholar]
- 45.Debray A, Gravel H, Garceau L, Bartlett AA, Chaseling GK, Barry H, et al. Finnish Sauna bathing and vascular health of adults with coronary artery disease: a randomized controlled trial. J Appl Physiol. (2023) 135(4):795–804. 10.1152/japplphysiol.00322.2023 [DOI] [PubMed] [Google Scholar]
- 46.Radtke T, Poerschke D, Wilhelm M, Trachsel LD, Tschanz H, Matter F, et al. Acute effects of Finnish sauna and cold-water immersion on haemodynamic variables and autonomic nervous system activity in patients with heart failure. Eur J Prev Cardiol. (2016) 23(6):593–601. 10.1177/2047487315594506 [DOI] [PubMed] [Google Scholar]
- 47.Alito A, Fontana JM, Franzini Tibaldeo E, Verme F, Piterà P, Miller E, et al. Whole-body cryostimulation in multiple sclerosis: a scoping review. J Clin Med. (2024) 13(7):2003. 10.3390/jcm13072003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Zalewski P, Klawe JJ, Pawlak J, Tafil-Klawe M, Newton J. Thermal and hemodynamic response to whole-body cryostimulation in healthy subjects. Cryobiology. (2013) 66(3):295–302. 10.1016/j.cryobiol.2013.03.006 [DOI] [PubMed] [Google Scholar]
- 49.Ziemann E, Olek RA, Kujach S, Grzywacz T, Antosiewicz J, Garsztka T, et al. Five-day whole-body cryostimulation, blood inflammatory markers, and performance in high-ranking professional tennis players. J Athl Train. (2012) 47(6):664–72. 10.4085/1062-6050-47.6.13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Rymaszewska J, Urbanska K, Szcześniak D, Pawłowski T, Pieniawska-Śmiech K, Kokot I, et al. Whole-body cryotherapy—promising add-on treatment of depressive disorders. Psychiatr Pol. (2019) 53(5):1053–67. 10.12740/PP/OnlineFirst/91298 [DOI] [PubMed] [Google Scholar]
- 51.Capodaglio P, Cremascoli R, Piterà P, Fontana JM. Whole-body cryostimulation: a rehabilitation booster. J Rehabil Med Clin Commun. (2022) 5:2810. 10.2340/jrmcc.v5.2810 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lubkowska A, Dołęgowska B, Szyguła Z. Whole-body cryostimulation–potential beneficial treatment for improving antioxidant capacity in healthy men–significance of the number of sessions. PLoS One. (2012) 7(10):e46352. 10.1371/journal.pone.0046352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Fontana JM, Alito A, Piterà P, Verme F, Cattaldo S, Cornacchia M, et al. Whole-body cryostimulation in post-COVID rehabilitation for patients with obesity: a multidisciplinary feasibility study. Biomedicines. (2023) 11(11):3092. 10.3390/biomedicines11113092 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Chun E, Joseph R, Pojednic R. Whole-body cryotherapy reduces systemic inflammation in healthy adults: pilot cohort study. Interact J Med Res. (2024) 13:e60942. 10.2196/60942 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Verme F, Majdič N, Modaffari G, Alito A, Scarpa A, Piterà P, et al. Whole-body cryostimulation: an effective complementary treatment in fibromyalgia? A follow up study. J Pers Med. (2024) 14(8):836. 10.3390/jpm14080836 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Rymaszewska J, Lion KM, Pawlik-Sobecka L, Pawłowski T, Szcześniak D, Trypka E, et al. Efficacy of the whole-body cryotherapy as add-on therapy to pharmacological treatment of depression-A randomized controlled trial. Front Psychiatry. (2020) 11:522. 10.3389/fpsyt.2020.00522 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Yin K, Zimmermann K, Vetter I, Lewis RJ. Therapeutic opportunities for targeting cold pain pathways. Biochem Pharmacol. (2015) 93(2):125–40. 10.1016/j.bcp.2014.09.024 [DOI] [PubMed] [Google Scholar]
- 58.Verme F, Fontana JM, Piterà P, Alito A, Saffioti S, Baccalaro G, et al. Whole-body cryostimulation in functional neurological disorders: a case report. Healthcare. (2023) 12(1):71. 10.3390/healthcare12010071 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Alito A, Quartarone A, Leonardi G, Tisano A, Bruschetta A, Cucinotta F, et al. Brown adipose tissue human biomarkers: which one fits best? A narrative review. Medicine. (2022) 101(48):e32181. 10.1097/MD.0000000000032181 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Muzik O, Mangner TJ, Leonard WR, Kumar A, Granneman JG. Sympathetic innervation of cold-activated brown and white fat in lean young adults. J Nucl Med. (2017) 58(5):799–806. 10.2967/jnumed.116.180992 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Peres Valgas da Silva C, Hernández-Saavedra D, White JD, Stanford KI. Cold and exercise: therapeutic tools to activate brown adipose tissue and combat obesity. Biology. (2019) 8(1):9. 10.3390/biology8010009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Alito A, Verme F, Mercati GP, Piterà P, Fontana JM, Capodaglio P. Whole body cryostimulation: a new adjuvant treatment in central sensitization syndromes? An expert opinion. Healthcare. (2024) 12(5):546. 10.3390/healthcare12050546 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Capodaglio P. Whole-body cryostimulation. Clin Appl. (2024). 10.1007/978-3-031-18545-8 [DOI] [Google Scholar]
- 64.Banfi G, Melegati G, Barassi A, d'Eril GM. Effects of the whole-body cryotherapy on NTproBNP, hsCRP and troponin I in athletes. J Sci Med Sport. (2009) 12(6):609–10. 10.1016/j.jsams.2008.06.004 [DOI] [PubMed] [Google Scholar]
- 65.Pournot H, Bieuzen F, Louis J, Fillard JR, Barbiche E, Hausswirth C. Time-course of changes in inflammatory response after whole-body cryotherapy multi exposures following severe exercise. PLoS One. (2011) 6(7):e22748. 10.1371/journal.pone.0022748 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Legrand FD, Dugué B, Costello J, Bleakley C, Miller E, Broatch JR, et al. Evaluating safety risks of whole-body cryotherapy/cryostimulation (WBC): a scoping review from an international consortium. Eur J Med Res. (2023) 28(1):387. 10.1186/s40001-023-01385-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Kelly EA, Forootan NS, Checketts JX, Frank A, Tangen CL. Retrospective analysis of whole-body cryotherapy adverse effects in division I collegiate athletes. J Osteopath Med. (2023) 123(5):249–57. 10.1515/jom-2022-0156 [DOI] [PubMed] [Google Scholar]
- 68.Greenwald E, Christman M, Penn L, Brinster N, Liebman TN. Cold panniculitis: adverse cutaneous effect of whole-body cryotherapy. JAAD Case Rep. (2018) 4(4):344–5. 10.1016/j.jdcr.2018.02.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.O'Connor M, Wang JV, Gaspari AA. Cold burn injury after treatment at whole-body cryotherapy facility. JAAD Case Rep. (2019) 5(1):29–30. 10.1016/j.jdcr.2018.10.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Capodaglio P, Alito A, Duguè BM, Bouzigon R, Lombardi G, Miller ED, et al. Contraindications to whole-body cryostimulation (WBC). A position paper from the WBC working group of the international institute of refrigeration and the multidisciplinary expert panel. Front Rehabil Sci. (2025) 6:1567402. 10.3389/fresc.2025.1567402 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Miller E, Kostka J, Włodarczyk T, Dugué B. Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study. Acta Neurol Scand. (2016) 134(6):420–6. 10.1111/ane.12557 [DOI] [PubMed] [Google Scholar]
- 72.Varallo G, Piterà P, Fontana JM, Gobbi M, Arreghini M, Giusti EM, et al. Is whole-body cryostimulation an effective add-on treatment in individuals with fibromyalgia and obesity? A randomized controlled clinical trial. J Clin Med. (2022) 11(15):4324. 10.3390/jcm11154324 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Alito A, Cifalinò ME, Fontana JM, Verme F, Piterà P, Capodaglio P. Tackling kinesiophobia in chronic shoulder pain: a case report on the combined effect of pain education and whole-body cryostimulation. J Clin Med. (2024) 13(7). 10.3390/jcm13072094 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Piterà P, Springhetti I, Alito A, Verme F, Fontana JM, Capodaglio P. Whole-body cryostimulation, a complementary treatment for phantom limb syndrome: preliminary evidence from a case study. Medicina (B Aires). (2023) 60(1):22. 10.3390/medicina60010022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Piterà P, Cremascoli R, Bianchi L, Borghesi F, Verme F, Cattaldo S, et al. Autonomic modulation in Parkinson’s disease using whole-body cryostimulation: a pilot study. Biomedicines. (2024) 12(11):2467. 10.3390/biomedicines12112467 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Piterà P, Bigoni M, Prina E, Barrera B, Yavuz DC, Verme F, et al. Is whole-body cryostimulation useful in modulating spasticity in adults with cerebral palsy? A case study. J Clin Med. (2024) 13(24):7674. 10.3390/jcm13247674 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Verhagen A, Bierma-Zeinstra S, Lambeck J, Cardoso JR, de Bie R, Boers M, et al. Balneotherapy for osteoarthritis. A cochrane review. J Rheumatol. (2008) 35(6):1118–23. [PubMed] [Google Scholar]
- 78.Joschko L, Pálsdóttir AM, Grahn P, Hinse M. Nature-based therapy in individuals with mental health disorders, with a focus on mental well-being and connectedness to nature-A pilot study. Int J Environ Res Public Health. (2023) 20(3):2167. 10.3390/ijerph20032167 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Pretty J, Barton J. Nature-based interventions and mind-body interventions: saving public health costs whilst increasing life satisfaction and happiness. Int J Environ Res Public Health. (2020) 17(21):7769. 10.3390/ijerph17217769 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Hardison ME, Roll SC. Mindfulness interventions in physical rehabilitation: a scoping review. Am J Occup Ther. (2016) 70(3):7003290030p1–9. 10.5014/ajot.2016.018069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Hu Y, Liu Y, Quan X, Fan W, Xu B, Li S. RBM3 Is an outstanding cold shock protein with multiple physiological functions beyond hypothermia. J Cell Physiol. (2022) 237(10):3788–802. 10.1002/jcp.30852 [DOI] [PubMed] [Google Scholar]

